BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23209540)

  • 1. Total synthesis and biological evaluation of fluorinated cryptophycins.
    Weiß C; Bogner T; Sammet B; Sewald N
    Beilstein J Org Chem; 2012; 8():2060-6. PubMed ID: 23209540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent approaches for the synthesis of modified cryptophycins.
    Weiss C; Sammet B; Sewald N
    Nat Prod Rep; 2013 Jul; 30(7):924-40. PubMed ID: 23732943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis.
    Nahrwold M; Weiß C; Bogner T; Mertink F; Conradi J; Sammet B; Palmisano R; Royo Gracia S; Preuße T; Sewald N
    J Med Chem; 2013 Mar; 56(5):1853-64. PubMed ID: 23387527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs.
    Schmidt JJ; Khatri Y; Brody SI; Zhu C; Pietraszkiewicz H; Valeriote FA; Sherman DH
    ACS Chem Biol; 2020 Feb; 15(2):524-532. PubMed ID: 31961651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting.
    Weiss C; Figueras E; Borbely AN; Sewald N
    J Pept Sci; 2017 Jul; 23(7-8):514-531. PubMed ID: 28661555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
    Shih C; Teicher BA
    Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel unit B cryptophycin analogues as payloads for targeted therapy.
    Figueras E; Borbély A; Ismail M; Frese M; Sewald N
    Beilstein J Org Chem; 2018; 14():1281-1286. PubMed ID: 29977395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches for the synthesis of functionalized cryptophycins.
    Sammet B; Bogner T; Nahrwold M; Weiss C; Sewald N
    J Org Chem; 2010 Oct; 75(20):6953-60. PubMed ID: 20857920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three new cryptophycins from Nostoc sp. GSV 224.
    Subbaraju GV; Golakoti T; Patterson GM; Moore RE
    J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
    Eissler S; Bogner T; Nahrwold M; Sewald N
    Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total Synthesis of Cryptophycins and Their 16-(3-Phenylacryloyl) Derivatives.
    Rej R; Nguyen D; Go B; Fortin S; Lavallée JF
    J Org Chem; 1996 Sep; 61(18):6289-6295. PubMed ID: 11667469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery.
    Borbély A; Figueras E; Martins A; Esposito S; Auciello G; Monteagudo E; Di Marco A; Summa V; Cordella P; Perego R; Kemker I; Frese M; Gallinari P; Steinkühler C; Sewald N
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30939768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
    Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
    Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
    Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
    Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxicity studies of new cryptophycin analogues.
    Liu WL; Zhang JC; Jiang FQ; Fu L
    Arch Pharm (Weinheim); 2009 Oct; 342(10):577-83. PubMed ID: 19714674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palladium-catalyzed coupling reactions on functionalized 2-trifluoromethyl-4-chromenone scaffolds. Synthesis of highly functionalized trifluoromethyl-heterocycles.
    Izquierdo J; Jain AD; Abdulkadir SA; Schiltz GE
    Synthesis (Stuttg); 2019 Mar; 51(6):1342-1352. PubMed ID: 31274934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor Agents. 211. Fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents.
    Xia Y; Yang ZY; Xia P; Hackl T; Hamel E; Mauger A; Wu JH; Lee KH
    J Med Chem; 2001 Nov; 44(23):3932-6. PubMed ID: 11689079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid entry into the cryptophycin core via an acyl-beta-lactam macrolactonization: total synthesis of cryptophycin-24.
    Eggen M; Nair SK; Georg GI
    Org Lett; 2001 Jun; 3(12):1813-5. PubMed ID: 11405718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.